(Q40707641)

22 September 2017

title

Pharmacokinetics of Intravenously Administered L-5-Hydroxytryptophan in Man (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

18 June 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

18 June 2022

author name string

I. Magnussen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A311987

18 June 2022

F. Nielsen-Kudsk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A311987

18 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=311987

18 June 2022

publication date

1 April 1979

1 reference

full work available at URL

22 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0773.1979.tb02335.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0773.1979.tb02335.x/fullpdf

18 June 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Acta pharmacologica et toxicologica

18 June 2022

published in

1 reference

22 September 2017

volume

44

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

308-314

1 reference

5-Hydroxytryptophan: A method for monitoring human plasma content during clinical administration

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam

18 June 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Manipulation of brain serotonin in the treatment of myoclonus

18 June 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Beneficial effects of serotonin precursors in postanoxic action myoclonus

18 June 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent

18 June 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements

18 June 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

The determination of 5-hydroxytryptophan and its metabolites in plasma following administration to man

18 June 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor

18 June 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

The Effects of Aromatic Amino Acid Decarboxylase Inhibitors on Plasma Concentrations of 5-Hydroxytryptophan in Man

18 June 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Post-hypoxic intention myoclonus treated with 5-hydroxytryptophan and an extracerebral decarboxylase inhibitor

18 June 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Pharmacokinetics of dipyridamole

18 June 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Concept of a Volume of Distribution and Possible Errors in Evaluation of This Parameter

18 June 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

An improved method for the determination of exogenous 5-hydroxytryptophan in plasma

18 June 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Profitable and Nonprofitable Drugs

18 June 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa

18 June 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486

18 June 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1979.TB02335.X

18 June 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=311987

18 June 2022

1 reference